Markus Puhlmann - 12 Dec 2023 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role
Chief Medical Officer
Signature
/s/ Markus Puhlmann
Issuer symbol
CATX
Transactions as of
12 Dec 2023
Net transactions value
$0
Form type
4
Filing time
14 Dec 2023, 18:44:17 UTC
Previous filing
13 Feb 2023
Next filing
19 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CATX Stock Options (right to buy) Award $0 +1,477,619 +105% $0.000000 2,885,688 12 Dec 2023 Common Stock 1,477,619 $0.2400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% vested as of 12/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 12/12/2024, until fully vested.